CAS 61422-45-5
:Carmofur
Description:
Carmofur, with the CAS number 61422-45-5, is a synthetic compound primarily recognized for its application in cancer treatment, particularly in the management of colorectal cancer. It is classified as a fluorinated derivative of uracil, which is a pyrimidine nucleobase. Carmofur exhibits antitumor activity by inhibiting the enzyme thymidylate synthase, thereby interfering with DNA synthesis and cell proliferation. The compound is typically administered orally and is known for its relatively low toxicity compared to other chemotherapeutic agents. In addition to its anticancer properties, Carmofur has also been studied for its potential neuroprotective effects, particularly in neurodegenerative diseases. Its chemical structure includes a fluorine atom, which contributes to its biological activity. As with many pharmaceuticals, the use of Carmofur may be accompanied by side effects, and its efficacy can vary among individuals. Overall, Carmofur represents a significant compound in the field of oncology and continues to be the subject of research for its therapeutic potential.
Formula:C11H16FN3O3
InChI:InChI=1S/C11H16FN3O3/c1-2-3-4-5-6-13-10(17)15-7-8(12)9(16)14-11(15)18/h7H,2-6H2,1H3,(H,13,17)(H,14,16,18)
InChI key:InChIKey=AOCCBINRVIKJHY-UHFFFAOYSA-N
SMILES:C(NCCCCCC)(=O)N1C(=O)NC(=O)C(F)=C1
Synonyms:- 1(2H)-pyrimidinecarboxamide, 5-fluoro-N-hexyl-3,4-dihydro-2,4-dioxo-
- 1-(Hexylcarbamoyl)-5-fluorouracil
- 1-(Hexylcarbamyl)-5-fluorouracil
- 1-(n-Hexylcarbamoyl)-5-fluorouracil
- 5-Fluoro-N-hexyl-2,4-dioxo-3,4-dihydropyrimidine-1(2H)-carboxamide
- 5-Fluoro-N-hexyl-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinecarboxamide
- 61422-45-5
- Mifurol
- Yamaful
- HCFU
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 11 products.
1(2H)-Pyrimidinecarboxamide, 5-fluoro-N-hexyl-3,4-dihydro-2,4-dioxo-
CAS:Formula:C11H16FN3O3Purity:99%Color and Shape:SolidMolecular weight:257.2614Carmofur
CAS:<p>Carmofur (HCFU) is a highly potent acid ceramidase inhibitor, used in the treatment of breast and colorectal cancer.</p>Formula:C11H16FN3O3Purity:98.53% - 99.98%Color and Shape:SolidMolecular weight:257.265-Fluoro-1-(hexylcarbamoyl)uracil
CAS:<p>5-Fluoro-1-(hexylcarbamoyl)uracil</p>Purity:98.5%Molecular weight:257.26g/molCarmofure
CAS:Formula:C11H16FN3O3Purity:≥ 98.0%Color and Shape:White or off-white powderMolecular weight:257.26Carmofur
CAS:Formula:C11H16FN3O3Purity:>98.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:257.27Carmofur
CAS:Controlled Product<p>Applications Carmofur is a derivative of fluorouracil (F596002) an is an antineoplastic agent showing antitumor activity against several cells including L1210 leukemia and L5178Y lymphoma cells.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Hoshi, A., et al.: J. Pharmacobio-dynam., 3, 478 (1980);<br></p>Formula:C11H16FN3O3Color and Shape:NeatMolecular weight:257.26Carmofur
CAS:<p>Carmofur is a fluorouracil derivative that interferes with nucleotide metabolism and consequently with synthesis of RNA and DNA, leading to cytotoxic and antineoplastic effects. Carmofur inhibits also other enzymes such as lysosomal acid ceramidase and the main protease from coronaviruses. For the SARS-CoV-2 main protease Mpro, carmofur was characterised as a covalent inhibitor with IC50 of 1.82 μM and EC50 of 24.30 μM.</p>Formula:C11H16FN3O3Purity:Min. 95%Color and Shape:White PowderMolecular weight:257.26 g/molCarmofur - Bio-X ™
CAS:<p>Carmofur is an antineoplastic agent that is used to treat various cancers such as breast and colorectal cancer. This drug is a derivative of fluorouracil. Carmofur is an inhibitor of the human acid ceramidase, a lysosomal amidase involved in the development of cancer cells.</p>Formula:C11H16FN3O3Purity:Min. 95%Color and Shape:PowderMolecular weight:257.26 g/mol







